Tellimer logo
Search icon
Equity Analysis
/United States of America

US : Pharmaceuticals - Specialty Pharmaceuticals | Sidelined Demand Is Beginning to Return to the RX Market as Generics Surpass Pre-COVID Rx Levels

    Contributors
    Lucas Lee
    Michael Parolari
    CGS-CIMB
    17 May 2021
    Published by

    Watchlist

    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.